6 Follicular Lymphoma Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Follicular Lymphoma Studies in Rochester

NCT04411823Recruiting

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy....

Rochester, MN200 participantsMayo Clinic

View Study Details

NCT05193968Recruiting

Hot Flashes and Neurovascular Function in Women

Women who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As s...

Rochester, MN120 participantsMayo Clinic

View Study Details

NCT05783609Recruiting

Epcoritamab and Rituximab for First-line Follicular Lymphoma

The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other trea...

Rochester, MN100 participantsReid Merryman, MD

View Study Details

NCT07219043Recruiting

A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

In this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition called microvascular inflammation (MVI). MVI ...

Rochester, MN81 participantsBiogen

View Study Details

NCT06798012Recruiting

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over...

Rochester, MN36 participantsTakeda

View Study Details

NCT06383585Recruiting

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection...

Rochester, MN25 participantsMayo Clinic

View Study Details

About Follicular Lymphoma Clinical Trials in Rochester

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 6 follicular lymphoma clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 562 participants. Research is being sponsored by Mayo Clinic, Reid Merryman, MD, Biogen and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Rochester — FAQ

Are there follicular lymphoma clinical trials in Rochester?

Yes, there are 6 follicular lymphoma clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 6 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated July 13, 2026 from ClinicalTrials.gov